VEGFA and neoplasm: Efforts to normalize the tumor vasculature to improve tumor tissue perfusion and immune function have been pursued by inhibiting the VEGF–receptor pathway in combination with immune checkpoint inhibitors in the treatment of metastatic renal cell carcinoma42 and hepatocellular carcinoma43.